Comment from Main Street Foundation Center for Regulatory Analysis and Engagement

AnonymousSupportAdvocacy
Summary: The Main Street Foundation's Center for Regulatory Analysis and Engagement (CRAE) supports the FDA's efforts to identify evidence-based drug repurposing opportunities within existing statutory frameworks. They argue for strengthening administrative processes through transparency, objective criteria, and technological modernization (like AI) while maintaining rigorous scientific standards.
Attached are comments from the Main Street Foundation Center for Regulatory Analysis and Engagement.

View on Regulations.gov